Altimmune
ALT
ALT
102 hedge funds and large institutions have $296M invested in Altimmune in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $375M → $296M (-$79.1M)
44% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 34
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
102
Holding in Top 10
1
Calls
$8.43M
Puts
$5.15M
Top Buyers
| 1 | +$12.6M | |
| 2 | +$8.77M | |
| 3 | +$8.22M | |
| 4 |
Barclays
London,
United Kingdom
|
+$7.44M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.47M |
Top Sellers
| 1 | -$43M | |
| 2 | -$16M | |
| 3 | -$8.05M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.92M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$5.42M |